la2ILabeled nerve growth factor binds to membrane preparations from superior cervical ganglia of rabbit in a specific fashion indicative of an interaction with the physiological receptor. Of various tissues examined, binding was observed only in the superior cervical ganglia, a presumed target organ of nerve growth factor. Binding of labeled factor is displaced by nonradioactive factor but not by several other peptide hormones. Binding to ganglia of preparations of nerve growth factor treated with N-bromosuccinimide closely parallels their biological activity. Binding of nerve growth factor receptor is saturable with an affinity constant of about 0.2 nM, similar to the reported plasma levels of the factor. Nerve growth factor does not elicit insulin-like biological effects in isolated adipocytes, and it does not modify the binding of
[125Ilinsulin or [l2511epidermal growth factor to fat cells or liver membranes.
Nerve growth factor (NGF) is an important regulator of growth and development of sympathetic neurons (1) . However, its exact mechanism of action is unclear and it is not certain whether its biological effects are restricted to the sympathetic and sensory nervous system. Selective accumulation of radioactive NGF by sympathetic ganglia (2) suggested that these ganglia might contain specific NGF-binding sites on their surface membranes. The similarities between the amino-acid sequences of NGF and proinsulin (3, 4) , as well as similarities in the nature of some of the biological activities of these two hormones in their respective target cells (1, 3) , suggested the possibility that the tissue receptors for NGF and insulin may possess some common features that could be investigated by procedures similar to those recently used to study insulin receptors (5) (6) (7) . This report describes procedures for measuring the specific binding of NGF to membrane preparations from sympathetic ganglia (8) and presents the salient features of this NGF-receptor interaction. METHODS
Fractionation of Rabbit Superior Cervical Ganglia. Sympathetic ganglia from young rabbits (Pel Freez, Birmingham, Ala.) and calves (Slaughterhouse, Baltimore, Md.) were homogenized in 10 volumes of 0.32 M sucrose containing 100 mM NaCl and 0.5 mM MgSOi with a Brinkmann Polytron Pt-10 (setting 2.2, 120 sec). The whole homogenate was centrifuged for 10 min at 1000 X g. The pellet (crude nuclear fraction) was suspended in 0.32 M sucrose containing 0.1 M NaCl and 0.5 mM MgSO4, and the previous step -was repeated. The two supernatant fractions were combined and centrifuged for 10 min at 7710 X g; the pellet (crude mitochondrial fracAbbreviation: NGF, nerve growth factor. * To whom reprint requests should be sent at the Department of Pharmacology.
tion) was suspended in Krebs-Tris buffer (pH 7.4) and the supernatant fluid was centrifuged for 60 min at 100,000 X g at 4°. The final pellet was suspended in Krebs-Tris buffer (2-5 mg of protein per ml) to obtain the crude microsomal fraction. This suspension was divided into multiple aliquots and stored either in liquid nitrogen or at -30°in a freezer. Stored in this way, binding of NGF receptor did not decline for at least 9 weeks. The protein content was measured (6) . Rabbit ganglia were obtained freshly frozen and fractionated 3-10 days after the animals were killed. Calf ganglia were obtained fresh, frozen, and assayed 2 days later. The 2.5S preparation of NGF, prepared by the method of Bocchini and Angeletti (9) , was used for all the experiments in this study unless otherwise indicated and will henceforth be referred to simply as NGF, while other preparations will be specifically designated. The (3-subunit of 7S NGF was prepared by the method of Varon et al. (10) . The biological activity of NGF preparations was assayed by measurement of neurite production in dissociated sympathetic cells of chick embryo (L. Greene, in preparation). In this assay, 10 units correspond to 1 unit in conventional bioassays for NGF (11) . This assay is more sensitive than the conventional bioassay and permits detection of changes in activity that vary by a factor of less than 2. In the conventional bioassay, one BU is referred to as the amount of NGF required to give a 4+, response in the tissue-culture system. The biological activity of NGF preparations used in this study varied from 30.0-40.0 units/,ug of protein when the unit is defined as described by Levi-Montalcini et al. (11) .
NGF was iodinated by procedures similar to those described for insulin (5) (6) (7) except that the sodium metabisulfite step was omitted. NGF (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) /Ag) was mixed with 1-3 mCi of freshly prepared, tracer-free Nal5I (Union Carbide) in 0.12 ml of 0.25 M sodium phosphate buffer (pH 7.4). Chloramine 
RESULTS
General Properties and Kinetics of Binding.
[1251]NGF binding is linearly dependent on the concentration of membrane protein of superior cervical ganglia over the range 1-10lg and plateaus beyond 20 Mg (Fig. 1 ). All assays were therefore conducted in the linear range. Competition for binding of [1251]NGF by native NGF was examined by incubation of membrane preparations of ganglia with [1251I]NGF (6 ng/ml) that was mixed with different concentrations of native NGF (Fig. 3) . The pattern of displacement observed is consistent with a similarity in the behavior of native and iodinated NGF with respect to binding to membrane receptors. The concentration required to achieve halfmaximal displacement of binding is about 7 ng/ml of native NGF (0.2 nM). The fact that half-maximal saturation ( (Fig.  4) . This information permits calculation (5) of the apparent bimolecular rate constant of NGF-receptor association al, which is 4 X 106 M-1 sec'. The rate of dissociation of the NGF-receptor complex can be measured directly at 240 and 40 (Fig. 4) . At 240 dissociation is linear when plotted semilogarithmically; the half-life of the complex is about 13 min.
The rate constant for dissociation at 240 is 9 X 10-4 sec'. Dissociation is very slow at 40; less than 20% of bound [125J] . NGF dissociates in 20 min. Subcellular Localization. To determine the relative amounts of NGF-binding activity in different subcellular fractions, we homogenized ganglia and subjected them to differential centrifugation ( Table 1 ). The highest specific activity of binding of [125I]NGF occurs in the crude microsomal fraction, which is enriched in membrane fragments. The specific activity of binding in the crude microsomal fraction is almost 10-times greater than that of the whole homogenate and about 13-times greater than that of the crude nuclear fraction, which contains the lowest specific activity of NGF binding. Of the total binding activity in the whole homogenate, 79% is recovered in the microsomal fraction. Since almost all of the binding activity of the homogenate is recovered in the three subcellular fractions, it is probable that only a negligible portion of the total binding activity is present in the supernatant fraction, which could not be assayed directly.
Tissue Distribution. To determine whether NGF binding represents binding to the physiological NGF receptor, we Fat cells 1390 1300
The indicated tissues, obtained from rabbits (except fat cells and calf ganglia), were homogenized in 10 volumes of 0.32 M sucrose with 100 mM Na+ and 0.5 mM Mg++. evaluated several tissues in addition to superior cervical ganglia ( The ability of NGF to interfere with the binding of [12EI1 epidermal growth factor to sympathetic ganglia was also examined. The limited amount of binding observed was not displaced by excess quantities of nonradioactive epidermal growth factor or NGF. Since epidermal growth factor and NGF are similar in their source (12) , the apparent failure of The binding experiment was done as described in the tezt and native NGF was treated with N-bromosuccinimide by the procedure of Spande and Witkop (13) . The specific binding of [12'I] NGF to ganglia microsomal preparations in the absence of NGF treated with N-bromosuccinimide was 3630 cpm.
epidermal growth factor to bind to the NGF receptor sites provides further evidence in support of the specificity of NGF binding.
Under various conditions it was not possible to demonstrate significant effects of native NGF on the specific binding of
[I261]insulin to intact fat cells or liver membranes (Table 4) .
NGF also does not modify the specific binding of [12'I] epidermal growth factor to liver membranes ( Table 4) .
As a further test of the physiological relevance of NGF binding, the biological activity of NGF was correlated with its ability to bind to membrane fragments of superior cervical ganglia of rabbits. NGF preparations were treated with various amounts of N-bromosuccinimide (13) , which destroys the biological activity of NGF by selectively oxidizing tryptophan residues (14) . Treated preparations of NGF with a range of biological activity were prepared ( was stimulated 5-fold by l-norepinephrine (20 ng/ml), and this response was 90% inhibited by insulin (1 ng/ml). The a-subunit of NGF caused no inhibition in concentrations varying from 10 ng/ml to 20 /Ag/ml. The 7S form of NGF also had no effects at concentrations less than 1 ,ug/ml; some inhibition, however, was demonstrated with 2 /Ag/ml (20%), 4 ,ug/ml (28%), and 10 ,g/ml (32%). NGF preparations had no significant lipolytic activity.
DISCUSSION
Binding of [1251]NGF to membrane fractions of superior cervical ganglia of rabbits appears to represent an interaction with the physiological receptor for NGF. Of the various tissues examined, only preparations of superior cervical ganglia display specific NGF binding. The binding is a saturable process over the concentration range of NGF that exists in the circulation and that is biologically effective in assays in vivo. Furthermore, the dissociation constant (about 0.2 nM) calculated from the kinetics of binding corresponds closely to that estimated from bioassays.
NGF binding is not modified by high concentrations of several other peptides, including proinsulin, whose aminoacid sequence bears similarities to NGF (3, 4), or epidermal growth factor, another growth-promoting hormone which, like NGF, is produced by salivary glands of mice. The close correlation of biological activity with receptor binding displayed by NGF samples treated with N-bromosuccinimide provides further evidence that the [125I]NGF binding observed here represents true receptor binding.
The binding assay used in the present study is simple, sensitive, and specific. It provides an efficient means for examining biological specimens for NGF-receptor interactions and might be useful in studies of pathological states, such as hyperthyroidism, hypertension, and malignant disease. We recently observed that human lymphocytes stimulated with concanavalin-A develop NGF receptors (manuscript in preparation) coincident with the emergence of insulin receptors (16) .
Like receptors for many hormones, the NGF receptors are localized to membrane fragments and may be present on the cell surface. The bimolecular nature of the association constant suggests that NGF binds to a single species of a receptor.
The dissociation constant calculated from the ratio of k11/k, Nerve Growth Factor Receptor 2523 (0.23 nM) is similar to the value of 0.2 nM calculated on the basis of the concentrations of free NGF and receptor and of their complex at equilibrium under nonsaturating conditions. This value is quite similar to plasma concentrations of NGF in mouse serum, which are 0.4 nM (17) . The recent demonstration that somatomedin ("sulfation factor", "thymidine factor"), a peptide hormone that has potent insulin-like activity on isolated fat cells, can effectively compete with ['251 ]insulin for binding to receptors in various tissues (18) has raised the possibility that other basically anabolic and growth-promoting hormones may possess some common receptor properties. This possibility seemed especially important for NGF since this hormone has metabolic effects on sympathetic ganglia that are similar to those of insulin on its target tissues, and since the primary structure of NGF has certain analogies to that of proinsulin, a hormone that activates insulin responses by binding to insulin receptors (19) . Our demonstration in these studies that proinsulin and insulin do not affect the binding of [1251] NGF, that NGF does not alter the binding of [1251 ]insulin, and that NGF does not elicit insulin-like effects in adipocytes indicates that the receptors for insulin and for NGF are highly specific and possess little or no cross reactivity, with respect to specificity. The receptors for NGF and for epidermal growth factor also do not demonstrate cross-specificity. Furthermore, no cross reactivity exists between the receptors for insulin *and for epidermal growth factor (manuscript in preparation). 
